← Eichor
Condition: Renal Anemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Renal Anemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney D
Phase 3 · 1 location(s) · Kind Pharmaceuticals LLC · NCT07487727Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis
Phase 4 · 1 location(s) · Chinese PLA General Hospital · NCT07045155Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients
Phase 1/Phase 2 · 1 location(s) · Mansoura University · NCT06903559The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With Aranesp
NA · 1 location(s) · Zealand University Hospital · NCT04330729Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Phase N/A · 1 location(s) · Swiss Tropical & Public Health Institute · NCT05881447Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT07175051A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatmen
Phase 3 · 21 location(s) · AMAG Pharmaceuticals, Inc. · NCT03619850Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Phase N/A · 7 location(s) · Alexion Pharmaceuticals, Inc. · NCT06312644A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible
NA · 24 location(s) · Guangdong Provincial People's Hospital · NCT07136792Comparing Reticulocyte Hemoglobin and Transferrin Saturation to Guide Iron Treatment in People on Dialysis
NA · 1 location(s) · King Chulalongkorn Memorial Hospital · NCT06906835Efficacy of INM004 in Children With STEC-HUS
Phase 3 · 52 location(s) · Inmunova S.A. · NCT06389474Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
NA · 26 location(s) · University of Calgary · NCT05219110The Burden of Atypical Hemolytic Uremic Syndrome and The Clinical Characteristics of Patients in Egyptian Hospitals A Mu
Phase N/A · 8 location(s) · AstraZeneca · NCT07218536A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus
EARLY_Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06653556Cooperative Assessment of Late Effects for SCD Curative Therapies
Phase N/A · 5 location(s) · Vanderbilt University Medical Center · NCT05153967Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS
Phase 3 · 9 location(s) · Novartis Pharmaceuticals · NCT05795140A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With An
Phase 3 · 1 location(s) · Kind Pharmaceuticals LLC · NCT07494409Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypi
Phase 3 · 31 location(s) · Novartis Pharmaceuticals · NCT05935215Oral Iron in Children With Chronic Kidney Disease
Phase 4 · 2 location(s) · Weill Medical College of Cornell University · NCT03991169Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Dise
Phase 3 · 2 location(s) · Biocad · NCT07119372FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.
Phase N/A · 1 location(s) · Maimónides Biomedical Research Institute of Córdoba · NCT05356325Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS
Phase 4 · 12 location(s) · Alexion Pharmaceuticals, Inc. · NCT07308574Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized Therapy
NA · 1 location(s) · Mario Negri Institute for Pharmacological Research · NCT05805202Impact of Dapagliflozin in Anemic Chronic Kidney Disease Patients
Phase 2 · 1 location(s) · Mansoura University · NCT06897605Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
Phase N/A · 141 location(s) · Alexion Pharmaceuticals, Inc. · NCT01522183Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium
Phase N/A · 1 location(s) · Maastricht University Medical Center · NCT04745195Integrated Diagnosis and Treatment of CKD on Outcomes
Phase N/A · 1 location(s) · Capital Medical University · NCT05242055The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
Phase N/A · 38 location(s) · Russian Federation of Anesthesiologists and Reanimatologists · NCT03945968
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.